PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
A1AT		Target	Disease	Inflammation
A1AT		Target	Disease	Liver Disease
A1AT		Target	Disease	Heart Disease
A1AT		Target	Disease	Warts
A-Methapred (Methylprednisolone Sodium Succinate)- FDA		Drug	Drug	Adalimumab (Humira)- FDA
744.1		Target	Disease	Carcinoma
744.1		Target	Disease	Acute Promyelocytic Leukemia
744.1		Target	Disease	Chronic Obstructive Pulmonary Disease
744.1		Target	Disease	Stroke
744.1		Target	Target	Adiponectin
744.1		Target	Target	464.1
744.1		Target	Disease	Hepatitis
744.1		Target	Disease	Cardiac Arrest
744.1		Target	Disease	Dyslipidemia
744.1		Target	Disease	Leukemia
744.1		Target	Disease	Inflammation
744.1		Target	Disease	Liver Disease
744.1		Target	Disease	Heart Disease
5-Hydroxytryptamine 2b Receptor		Target	Disease	Central Nervous System Diseases
5-Hydroxytryptamine 2b Receptor		Target	Disease	Obesity
5-Hydroxytryptamine 2b Receptor		Target	Target	ERK1
5-Hydroxytryptamine 2b Receptor		Target	Target	5-Hydroxytryptamine 2a Receptor
5-Hydroxytryptamine 2b Receptor		Target	Target	Collagen
5-Hydroxytryptamine 2b Receptor		Target	Disease	Migraine
5-Hydroxytryptamine 2b Receptor		Target	Disease	Amyotrophic Lateral Sclerosis
5-Hydroxytryptamine 2b Receptor		Target	Target	D(2) Dopamine Receptor
5-Hydroxytryptamine 2b Receptor		Target	Target	Elastase
5-Hydroxytryptamine 2b Receptor		Target	Disease	Liver Disease
5-Hydroxytryptamine 2b Receptor		Target	Disease	Heart Disease
5-Hydroxytryptamine 2a Receptor		Target	Target	Collagen
5-Hydroxytryptamine 2a Receptor		Target	Target	Sphingomyelinase
5-Hydroxytryptamine 2a Receptor		Target	Target	EGF
5-Hydroxytryptamine 2a Receptor		Target	Disease	Mania
5-Hydroxytryptamine 2a Receptor		Target	Disease	Psoriasis
5-Hydroxytryptamine 2a Receptor		Target	Disease	Autism
5-Hydroxytryptamine 2a Receptor		Target	Disease	Pain
5-Hydroxytryptamine 2a Receptor		Target	Target	BDNF
5-Hydroxytryptamine 2a Receptor		Target	Disease	Seizures
5-Hydroxytryptamine 2a Receptor		Target	Disease	Inflammation
464.1		Target	Disease	Hypotension
464.1		Target	Disease	Cholesterol
464.1		Target	Disease	Leukemia
464.1		Target	Disease	Asthma
464.1		Target	Disease	Inflammation
4-Mercaptopyridine		Drug	Disease	Cancer
4-Mercaptopyridine		Drug	Drug	4-Mercaptobenzoic Acid
4-Mercaptopyridine		Drug	Disease	Leukemia
4-Mercaptopyridine		Drug	Drug	Doxorubicin
4-Mercaptopyridine		Drug	Disease	Glioblastoma
4-Mercaptobenzoic Acid		Drug	Disease	Hepatitis
4-Mercaptobenzoic Acid		Drug	Disease	Malaria
4-1BB Receptor		Target	Disease	Conjunctivitis
4-1BB Receptor		Target	Disease	Tuberculosis
4-1BB Receptor		Target	Disease	Infection
4-1BB Receptor		Target	Target	4-1BB Ligand
4-1BB Receptor		Target	Disease	Lung Carcinoma
4-1BB Receptor		Target	Disease	Influenza
4-1BB Receptor		Target	Disease	Shock
4-1BB Receptor		Target	Target	Collagen
4-1BB Receptor		Target	Target	CD137
4-1BB Receptor		Target	Disease	Leukemia
4-1BB Receptor		Target	Disease	Inflammation
4-1BB Ligand		Target	Disease	Multiple Myeloma
4-1BB Ligand		Target	Disease	Lung Carcinoma
4-1BB Ligand		Target	Target	ERK1
4-1BB Ligand		Target	Disease	Influenza
4-1BB Ligand		Target	Disease	Organ Transplantation
4-1BB Ligand		Target	Disease	Arthritis
4-1BB Ligand		Target	Disease	Chronic Lymphocytic Leukemia
4-1BB Ligand		Target	Disease	Rheumatoid Arthritis
4-1BB Ligand		Target	Disease	Keratitis
4-1BB Ligand		Target	Target	Collagen
4-1BB Ligand		Target	Disease	Leukemias
4-1BB Ligand		Target	Target	CCL3
4-1BB Ligand		Target	Disease	Myelodysplastic Syndrome
4-1BB Ligand		Target	Target	CD137
4-1BB Ligand		Target	Disease	Sepsis
4-1BB Ligand		Target	Target	BTK
4-1BB Ligand		Target	Disease	Leukemia
4-1BB Ligand		Target	Disease	Breast Cancer
4-1BB Ligand		Target	Disease	Asthma
4-1BB Ligand		Target	Target	CD34
4-1BB Ligand		Target	Disease	Inflammation
4-1BB Ligand		Target	Drug	Doxorubicin
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Obesity
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Carcinoma
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	ASK1
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Depression
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Cancer
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Drug	Doxazosin
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	AKT2
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	Calmodulin
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Ovarian Cancer
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Anxiety
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Prostate Cancer
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Hyperglycemia
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Infection
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	AKT3
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Viral Disease
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Lung Carcinoma